Partner and Co-chair,
Morrison & Foerster
Kate Murashige, a patent attorney whose practice focuses on the pharmaceutical and healthcare industries, has practiced law since 1977. She was associated with the firm of Lyon & Lyon of Los Angeles and was in corporate practice at Syntex. In 1983, she left Genentech to form Ciotti & Murashige, which became one of the nation's premier biotechnology and bioscience practices. She joined Morrison & Foerster in 1991 along with the rest of the Ciotti & Murashige group. Prior to practicing law, she taught chemistry and was chair of Physical Sciences at the College of San Mateo for six years.
Dr. Murashige is a member of the AAAS committee on Scientific Freedom and Responsibility. She formerly was president of the Peninsula Intellectual Property Law Association and a member of the board of the United States Patent and Trademark Office Biotechnology Institute. She also served on the former National Biotechnology Policy Board for NIH and as chair of the Biotechnology Committee of the American Intellectual Property Law Association. She has spoken at the Human Genome Conference on patent matters and to members of Congress and their staffs regarding the Human Genome Project, and was an advisor on gene patenting to the Office of Technology Assessment. Her peers chose her as one of the "Best Lawyers in Washington."
She received a B.A. from Washington University in St. Louis, a Ph.D. in chemistry from UCLA, and her J.D. from Santa Clara University School of Law.